ArticleBMC infectious diseases2021

A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model.

Lorenzo Argante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.